Octylseal Surgical Adhesive in General Surgery

May 6, 2019 updated by: Medline Industries

Evaluation of Octylseal as a Topical Surgical Skin Incision Adhesive in General Surgery: A Case Series

The purpose of this study is to evaluate how surgical adhesive is used.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

In this Case Series Study, clinician experience and subject outcomes will be recorded in the use of a topical skin adhesive (Octylseal) on the closure of skin incisions from General surgical procedures.

Study Type

Interventional

Enrollment (Actual)

34

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New Jersey
      • Jersey City, New Jersey, United States, 07302
        • Jersey City Medical Center
    • New York
      • New York, New York, United States, 11237
        • Wyckoff Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Candidate for use of a topical surgical skin adhesive

Exclusion Criteria:

  • Subjects with know sensitivity to topical surgical tissue adhesive products or degrading products (cyanoacrylates or formaldehyde)
  • Subjects with a history of keloid formation, hypotension, insulin dependent diabetes mellitus, blood/clotting disorders, peripheral vascular diseases or hypertrophy history
  • Subjects who present with a contraindications for product usage as per labeling
  • A wound with evidence of active infection or gangrene or wounds of decubitus etiology
  • Mucosal surfaces or across mucocutaneous junctions or skin that might be exposed to bodily fluids or with dense natural hair
  • Subjects with known hypersensitivity to cyanoacrylate or formaldehyde

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Surgical Adhesive
The surgical adhesive (cyanoacrylate) will be used once to close the topical skin surgical incision created during surgical procedures.
surgical adhesive
Other Names:
  • cyanoacrylate

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wound Length Closure
Time Frame: During Surgery
Primary incision wound length treatment in adult and pediatric general surgery
During Surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants With a Score of "0" (No Hurt) on the Pain Rating Scale
Time Frame: At Surgery
Pain was assessed using the Wong-Baker FACES™ Pain Rating Scale, with 0 =No Hurt to 10=Hurts Worst
At Surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2012

Primary Completion (Actual)

September 1, 2012

Study Completion (Actual)

October 1, 2012

Study Registration Dates

First Submitted

January 12, 2012

First Submitted That Met QC Criteria

January 20, 2012

First Posted (Estimate)

January 23, 2012

Study Record Updates

Last Update Posted (Actual)

May 7, 2019

Last Update Submitted That Met QC Criteria

May 6, 2019

Last Verified

May 1, 2019

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • R11-009

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Wounds

Clinical Trials on Cyanoacrylate (Octylseal )

Subscribe